Beta-Blockers After Myocardial Infarction: To Stop or Continue? The ABYSS Study Unveiled
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
Beta-Blockers After Myocardial Infarction: To Stop or Continue? The ABYSS Study Unveiled
-
Narrated by:
-
Written by:
In this episode of the Heartbeat Podcast, we explore the groundbreaking ABYSS trial, which investigates the controversial topic of beta-blocker therapy in patients with a history of myocardial infarction. Should beta-blockers be continued indefinitely, or is it safe to discontinue them after stabilization? Join us as we delve into the study's methods, findings, and implications for clinical practice. We discuss key outcomes, such as cardiovascular events and quality of life, to provide a comprehensive understanding of this pivotal research.
Listen now to discover how this study could reshape post-myocardial infarction care and spark new discussions in cardiology.
Links to the Podcast
- Apple Podcast: Listen on Apple Podcast
- Spotify: Listen on Spotify
- Amazon Music: Listen on Amazon Music
- YouTube: Watch on YouTube
#Cardiology #ABYSSStudy #BetaBlockers #MyocardialInfarction #CardiacCare #ClinicalResearch #HeartHealth #MedicalPodcast #CardiovascularDisease #HealthcareProfessionals